Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination of Prednisolone and Calcineurin Inhibitors Prevents Lung Function Decline in Patients with Anti-aminoacyl-tRNA Synthetase Antibody-Positive Polymyositis/Dermatomyositis.
Yorishima Y, Tominaga M, Fujimoto K, Nagata S, Sumi A, Chikasue T, Okamoto M, Kaieda S, Matama G, Zaizen Y, Obara H, Kakuma T, Ida H, Kawayama T, Hoshino T. Yorishima Y, et al. Among authors: kawayama t. Kurume Med J. 2023 Nov 30;69(1.2):19-30. doi: 10.2739/kurumemedj.MS6912002. Epub 2023 Aug 7. Kurume Med J. 2023. PMID: 37544752 Free article.
Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy-controlled, phase 2 multicenter study (ONE-BRIDGE).
Ichikado K, Kotani T, Kondoh Y, Imanaka H, Johkoh T, Fujimoto K, Nunomiya S, Kawayama T, Sawada M, Jenkins E, Tasaka S, Hashimoto S. Ichikado K, et al. Among authors: kawayama t. Stem Cell Res Ther. 2023 Aug 22;14(1):217. doi: 10.1186/s13287-023-03451-z. Stem Cell Res Ther. 2023. PMID: 37608287 Free PMC article. Clinical Trial.
Efficacy and safety of once-daily single-inhaler triple therapy for mild-to-moderate chronic obstructive pulmonary disease: a study protocol for a randomised and interventional study.
Takahashi K, Kawayama T, Takamori A, Tashiro H, Kinoshita T, Takagi K, Yamasaki K, Machida K, Kawaguchi A, Yatera K, Inoue H; TRACK (Triple therapy for Japanese with mild to moderate COPD in Kyushu) study investigator group. Takahashi K, et al. Among authors: kawayama t. BMJ Open Respir Res. 2023 May;10(1):e001607. doi: 10.1136/bmjresp-2022-001607. BMJ Open Respir Res. 2023. PMID: 37197795 Free PMC article.
The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Tanimura K, Sato S, Fujita Y, Yamamoto Y, Hajiro T, Horita N, Kawayama T, Muro S. Tanimura K, et al. Among authors: kawayama t. Chron Respir Dis. 2023 Jan-Dec;20:14799731231166008. doi: 10.1177/14799731231166008. Chron Respir Dis. 2023. PMID: 36967224 Free PMC article.
128 results